The Biologically Active Biopolymer Silk: The Antibacterial Effects of Solubilized Bombyx mori Silk Fibroin with Common Wound Pathogens
Source abstract
Abstract
Abstract Antibacterial properties are desirable in wound dressings. Silks, among many material formats, have been investigated for use in wound care. However, the antibacterial properties of liquid silk are poorly understood. The aim of this study is to investigate the inherent antibacterial properties of a Bombyx mori silk fibroin solution. Silk fibroin solutions containing ≥ 4% w/v silk fibroin do not support the growth of two common wound pathogens, Staphylococcus aureus and Pseudomonas aeruginosa. When liquid silk is added to a wound pad and placed on inoculated culture plates mimicking wound fluid, silk is bacteriostatic. Viability tests of the bacterial cells in the presence of liquid silk show that cells remain intact within the silk but could not be cultured. Liquid silk appears to provide a hostile environment for S. aureus and P. aeruginosa and inhibits growth without disrupting the cell membrane. This effect can be beneficial for wound healing and supports future healthcare applications for silk. This observation also indicates that liquid silk stored prior to processing is unlikely to experience microbial spoilage.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Silk-based biomaterials and applications · Silkworms and Sericulture Research · Antimicrobial Peptides and Activities
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering University of Strathclyde Glasgow G4 0NW UK
Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde 161 Cathedral Street Glasgow G4 0RE UK
Branch Bioresources Fraunhofer Institute for Molecular Biology & Applied Ecology Ohlebergsweg 12 35392 Giessen Germany
Institute of Pharmacy Friedrich Schiller University Jena Lessingstr. 8 07743 Jena Germany
Funding
Engineering and Physical Sciences Research Council · Higher Education Funding Council for England
References (60)
Show source-provided references
1. 10.1098/rsob.20022310.1098/rsob.200223 ↗
2. 10.1177/002203450935912510.1177/0022034509359125 ↗
3. 10.1128/CMR.14.2.244-269.200110.1128/CMR.14.2.244-269.2001 ↗
4. 10.1111/iwj.1204910.1111/iwj.12049 ↗
5. Taylor T. · 2021
6. Iglewski B. · 1996 · Chapter27
7. 10.1038/s41374-020-00478-110.1038/s41374-020-00478-1 ↗
8. 10.3934/bioeng.2017.2.23910.3934/bioeng.2017.2.239 ↗
9. 10.4155/tde-2018-001610.4155/tde-2018-0016 ↗
10. 10.1038/s41598-022-07437-410.1038/s41598-022-07437-4 ↗
11. Schiefer J. L. · Int. Wound J. · 2021 · 19 · 24
12. 10.1038/srep4436410.1038/srep44364 ↗
13. 10.1016/j.actbio.2019.11.05010.1016/j.actbio.2019.11.050 ↗
14. Holland C. · Future · 2019 · 8
15. 10.1002/adhm.20170012110.1002/adhm.201700121 ↗
16. 10.1097/GOX.000000000000355610.1097/GOX.0000000000003556 ↗
17. 10.1371/journal.pone.018815410.1371/journal.pone.0188154 ↗
18. 10.1002/bip.2232310.1002/bip.22323 ↗
19. 10.1016/S0964-8305(98)00050-X10.1016/S0964-8305(98)00050-X ↗
20. 10.1016/0923-1811(93)90046-R10.1016/0923-1811(93)90046-R ↗
21. Nuchadomrong S. · Int. J. Wild Silkmoth Silk · 2009 · 13 · 69
22. 10.1002/rcm.521310.1002/rcm.5213 ↗
23. 10.1111/wrr.1304910.1111/wrr.13049 ↗
24. 10.1016/j.mtchem.2021.10067310.1016/j.mtchem.2021.100673 ↗
25. Tabei Y. · Sens. Mater. · 2011 · 23 · 195
26. 10.1007/s40204-015-0039-x10.1007/s40204-015-0039-x ↗
27. 10.1016/j.msec.2014.07.00110.1016/j.msec.2014.07.001 ↗
28. 10.1021/acsomega.7b0121010.1021/acsomega.7b01210 ↗
29. 10.1007/s12221-010-0021-010.1007/s12221-010-0021-0 ↗
30. 10.1002/mabi.20150001310.1002/mabi.201500013 ↗
31. 10.1002/mabi.20130032110.1002/mabi.201300321 ↗
32. 10.1016/j.msec.2012.10.01610.1016/j.msec.2012.10.016 ↗
33. 10.1016/j.actbio.2013.08.03510.1016/j.actbio.2013.08.035 ↗
34. 10.4028/www.scientific.net/AMR.311-313.175510.4028/www.scientific.net/AMR.311-313.1755 ↗
35. 10.1046/j.1472-765x.2001.00976.x10.1046/j.1472-765x.2001.00976.x ↗
36. 10.1038/s41598-021-85199-110.1038/s41598-021-85199-1 ↗
37. 10.1038/s41467-022-35505-w10.1038/s41467-022-35505-w ↗
38. 10.3390/molecules1609790910.3390/molecules16097909 ↗
39. Frobose N. J. · Microbiol. Spectr. · 2021 · 9
40. 10.4236/jbise.2011.4505010.4236/jbise.2011.45050 ↗
41. 10.7717/peerj-matsci.810.7717/peerj-matsci.8 ↗
42. Allen L. · Int. J. Pharm. Compd. · 2018 · 22 · 288
43. 10.1111/1751-7915.1398010.1111/1751-7915.13980 ↗
44. 10.1046/j.1472-765X.2003.01345.x10.1046/j.1472-765X.2003.01345.x ↗
45. Cundell T. · Eur. Pharm. Rev. · 2015 · 20 · 58
46. 10.1007/978-1-4939-2578-0_1910.1007/978-1-4939-2578-0_19 ↗
47. 10.3390/antibiotics1011133910.3390/antibiotics10111339 ↗
48. 10.1128/AAC.48.10.3782-3788.200410.1128/AAC.48.10.3782-3788.2004 ↗
49. 10.3389/fimmu.2020.59028510.3389/fimmu.2020.590285 ↗
50. 10.1186/1476-0711-7-210.1186/1476-0711-7-2 ↗
51. 10.1016/j.ijbiomac.2022.10.10310.1016/j.ijbiomac.2022.10.103 ↗
52. 10.3390/polym1212298510.3390/polym12122985 ↗
53. 10.1111/cmi.1229410.1111/cmi.12294 ↗
54. 10.1080/00405000.2011.58615110.1080/00405000.2011.586151 ↗
55. 10.1016/j.peptides.2008.03.01310.1016/j.peptides.2008.03.013 ↗
56. 10.1093/nar/28.12.241310.1093/nar/28.12.2413 ↗
57. 10.1186/s40064-015-1476-710.1186/s40064-015-1476-7 ↗
58. 10.1021/acsbiomaterials.0c0102810.1021/acsbiomaterials.0c01028 ↗
59. 10.1080/1061186X.2017.136321210.1080/1061186X.2017.1363212 ↗
60. 10.1021/ma061010910.1021/ma0610109 ↗